Expression of the inhibitor of apoptosis protein survivin in benign meningiomas

Cancer Letters

Volumn 193, Issue 2, 2003, Pages 217-223

  Das, Asha ^a   Tan, Wan Loo ^a   Smith, Duncan R ^b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Bax; bcl2; Meningioma; Survivin

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037466467     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00741-3     Document Type: Article

References (35)

1. Bondy M., Ligon B.L. Epidemiology and etiology of intracranial tumours: a review. J. Neurooncol. 29:1996;197-205.
2. Das A., Tang W.-Y., Smith D.R. Meningiomas in Singapore: Demographic and biological characteristics. J. Neurooncol. 47:2000;153-160.
3. Helseth A., Mork S.J., Glattre E. Neoplasms of the central nervous system in Norway. V. Meningioma and cancer of other sites. An analysis of the occurrence of multiple primary neoplasms in meningioma patients in Norway from 1955 through 1986, Apmis. 97:1989;738-744.
4. Prayson R.A. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. Am. J. Clin. Pathol. 105:1996;719-726.
5. DeLong M.J. Apoptosis: a modulator of cellular homeostasis and disease states. Ann. N.Y. Acad. Sci. 842:1998;82-90.
6. Daniel P.T. Dissecting the pathways to death. Leukemia. 14:2000;2035-2044.
7. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. Trends Biochem. Sci. 22:1997;299-306.
8. Salvesen G.S., Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell. 91:1997;443-446.
9. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
10. Clem R.J., Miller L.K. of programmed cell death by the baculovirus genes p35 and iap. Mol. Cell. Biol. 14:1994;5212-5222.
11. Hay B.A., Wassarman D.A., Rubin G.M. Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death. Cell. 83:1995;1253-1262.
12. Verhagen A.M., Coulson E.J., Vaux D.L. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol. 2:2001;3009.01-3009.10.
13. Crook N.E., Clem R.J., Miller L.K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67:1993;2168-2174.
14. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:1997;917-921.
15. Tamm I., Wang Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf T., Reed J.C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95). Bax, caspases, and anticancer drugs, Cancer Res. 58:1998;5315-5320.
16. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., Oh B.H. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry. 40:2001;1117-1123.
17. Ambrosini G., Adida C., Sirugo G., Altieri D.C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem. 273:1998;11177-11182.
18. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:1998;580-584.
19. Krieg A., Mahotka C., Krieg T., Grabsch H., Muller W., Takeno S., Suschek C.V., Heydthausen M., Gabbert H.E., Gerharz C.D. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br. J. Cancer. 86:2000;737-743.
20. Wurl P., Kappler M., Meye A., Bartel F., Kohler T., Lautenschlager C., Bache M., Schmidt H., Taubert H. Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma. Lancet. 359:2002;943-945.
21. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6:2000;127-134.
22. Sarela A.I., Macadam R.C., Farmery S.M., Markham A.F., Guillou P.J. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 46:2000;645-650.
23. Azuhata T., Scott D., Takamizawa S., Wen J., Davidoff A., Fukuzawa M., Sandler A. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. J. Pediatr. Surg. 36:2001;1785-1791.
24. Chakravarti A., Noll E., Black P.M., Finkelstein D.F., Finkelstein D.M., Dyson N.J., Loeffler J.S. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 20:2002;1063-1068.
25. Hsu S.-M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem. 29:1981;577-580.
26. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell. Biol. 119:1992;493-501.
27. Lau K.E. Singapore census of population 1990. Statistical Release 1: Demographics and Characteristics. Department of Statistics, Singapore. 1992.
28. Sasaki T., Lopes M.B., Hankins G.R., Helm G.A. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol. (Berl.). 104:2002;105-109.
29. Sarela A.I., Verbeke C.S., Ramsdale J., Davies C.L., Markham A.F., Guillou P.J. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br. J. Cancer. 86:2002;886-892.
30. Lu C.D., Altieri D.C., Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 58:1998;1808-1812.
31. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., Tanigawa N. of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58:1998;5071-5074.
32. Saitoh Y., Yaginuma Y., Ishikawa M. Analysis of Bcl-2. Bax and Survivin genes in uterine cancer. Int. J. Oncol. 15:1999;137-141.
33. Kawasaki H., Toyoda M., Shinohara H., Okuda J., Watanabe I., Yamamoto T., Tanaka K., Tenjo T., Tanigawa N. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer. 91:2001;2026-2032.
34. Konno R., Yamakawa H., Utsunomiya H., Ito K., Sato S., Yajima A. Expression of survivin and Bcl-2 in the normal human endometrium. Mol. Hum. Reprod. 6:2000;529-534.
35. McLean C.A., Jolley D., Cukier E., Giles G., Gonzales M.F. Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology. 23:1993;349-353.